The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(4-Fluorophenyl)-4-methyl-6-(morpholinomethyl)-2-thiazol-2-yl-1H-pyrimidine-5-carboxylic Acid ID: ALA4520466
PubChem CID: 155542275
Max Phase: Preclinical
Molecular Formula: C20H21FN4O3S
Molecular Weight: 416.48
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC1(c2ccc(F)cc2)N=C(c2nccs2)NC(CN2CCOCC2)=C1C(=O)O
Standard InChI: InChI=1S/C20H21FN4O3S/c1-20(13-2-4-14(21)5-3-13)16(19(26)27)15(12-25-7-9-28-10-8-25)23-17(24-20)18-22-6-11-29-18/h2-6,11H,7-10,12H2,1H3,(H,23,24)(H,26,27)
Standard InChI Key: KVUKEXLKJJBZDL-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
10.9101 -9.2491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4343 -9.8737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1397 -10.2824 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1397 -11.0993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4343 -11.5158 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.7248 -11.0993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7248 -10.2824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0220 -9.8733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3134 -10.2794 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.0220 -9.0584 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.0160 -11.5079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0160 -12.3229 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3054 -12.7245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3054 -13.5456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0091 -13.9609 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.7238 -13.5515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7238 -12.7305 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8492 -11.5079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5957 -11.1723 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.1419 -11.7792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7387 -12.4854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9391 -12.3179 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.9584 -9.2491 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6758 -8.4800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2076 -7.8576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0145 -8.0021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2896 -8.7692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7654 -9.3937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5385 -7.3768 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
4 3 2 0
5 4 1 0
6 5 1 0
7 6 2 0
2 7 1 0
7 8 1 0
8 9 2 0
8 10 1 0
6 11 1 0
11 12 1 0
12 13 1 0
14 13 1 0
15 14 1 0
16 15 1 0
17 16 1 0
12 17 1 0
4 18 1 0
18 19 1 0
20 19 1 0
21 20 2 0
22 21 1 0
18 22 2 0
2 23 1 0
23 24 2 0
25 24 1 0
26 25 2 0
27 26 1 0
28 27 2 0
23 28 1 0
26 29 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 416.48Molecular Weight (Monoisotopic): 416.1318AlogP: 2.22#Rotatable Bonds: 5Polar Surface Area: 87.05Molecular Species: ACIDHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.26CX Basic pKa: 5.55CX LogP: -0.41CX LogD: -1.66Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.78Np Likeness Score: -1.17
References 1. Qiu Z, Lin X, Zhou M, Liu Y, Zhu W, Chen W, Zhang W, Guo L, Liu H, Wu G, Huang M, Jiang M, Xu Z, Zhou Z, Qin N, Ren S, Qiu H, Zhong S, Zhang Y, Zhang Y, Wu X, Shi L, Shen F, Mao Y, Zhou X, Yang W, Wu JZ, Yang G, Mayweg AV, Shen HC, Tang G.. (2016) Design and Synthesis of Orally Bioavailable 4-Methyl Heteroaryldihydropyrimidine Based Hepatitis B Virus (HBV) Capsid Inhibitors., 59 (16): [PMID:27458651 ] [10.1021/acs.jmedchem.6b00879 ]